YAVNE, Israel, Feb. 04, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics ...

Oppenheimer analyst Ken Wong lowered the firm’s price target on Bill (BILL) to $90 from $110 and keeps an Outperform rating on the shares. The ...

Over the years, we’ve heard hundreds of time about how we have enough nuclear weapons to destroy the world. But is that ...

Beauty stock is down Friday after the cosmetics company reported mixed results and trimmed its full-year guidance. Here's ...

In a report released today, Bryan Keane from Deutsche Bank maintained a Buy rating on Bill.com Holdings (BILL – Research Report), with a price ...

Benny Safdie is the latest actor to join the cast of The Odyssey, the next movie from Christopher Nolan, according to The ...

Shares of Pinterest surged after the company reported its highest monthly active user count on record and Wall Street analysts praised its guidance for the first quarter. The stock opened the market ...

Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is ...

This year’s Doomsday Clock Statement landed like a damp squib in a Trump-swamped corporate news cycle on January 28th. The ...

British consumers’ appetite for home entertainment reached new heights in 2024, with the sector surpassing £5.1 billion ($6.4 ...

Oppenheimer analysts reiterated their Outperform rating and $115.00 price target for EnerSys (NYSE:ENS) stock. EnerSys shares experienced a modest increase on Thursday following the company's ...